iOS app Android app

FDA 23andMe

Why We Should All Be Thrilled About the FDA Starting to Embrace Innovation

Vivek Wadhwa | Posted 05.03.2015 | Technology
Vivek Wadhwa

The FDA's approval of the marketing of genetics-testing company 23andMe's carrier test for Bloom syndrome affirmed the rights of consumers to drive their own healthcare decisions and procedures. But it also means that it has become urgent to develop policies to regulate the rights of companies to resell data derived from the contents of our DNA and from our medical records.

FDA Tells Google-Backed Startup To Stop Selling Genetic Tests

AP | MATTHEW PERRONE | Posted 01.25.2014 | Technology

WASHINGTON (AP) — The Food and Drug Administration has ordered Google-backed genetic test maker 23andMe to halt sales of its personalized DNA test k...